Other
2031 and thereafter
Guardant Health 2031 and thereafter decreased by 35.2% to $64.15M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 20.6%, from $80.83M to $64.15M.
Analysis
StatementBalance Sheet Statement
SectionOther
First reportedQ1 2024
Last reportedQ1 2026May 7, 2026
Metric ID:
other_lessee_operating_lease_liability_to_be_paid_after__de94b3Historical Data
7 periods
| Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|
| Value | $101.84M | $101.84M | $103.78M | $80.83M | $98.96M | $98.96M | $64.15M |
| QoQ Change | — | +0.0% | +1.9% | -22.1% | +22.4% | +0.0% | -35.2% |
| YoY Change | — | — | — | -20.6% | -2.8% | -4.6% | -20.6% |
Range$64.15M – $103.78M
CAGR-26.5%
Avg YoY Growth-12.2%
Median YoY Growth-12.6%
Frequently Asked Questions
- What is Guardant Health's 2031 and thereafter?
- Guardant Health (GH) reported 2031 and thereafter of $64.15M in Q1 2026.
- How has Guardant Health's 2031 and thereafter changed year-over-year?
- Guardant Health's 2031 and thereafter decreased by 20.6% year-over-year, from $80.83M to $64.15M.